PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsnontuberculous mycobacterium infections
MeSH D009165 - nontuberculous mycobacterium infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D009164:Mycobacterium infections
51 Companies
15 Drugs
$
Success rate
D009165: 
Nontuberculous mycobacterium infections
44 Companies
8 Drugs
$
Success rate
D007918:Leprosy
13 Companies
4 Drugs
$
Success rate
D010283:Paratuberculosis
0 Companies
0 Drugs
Success rate
D015270:Mycobacterium avium-intracellulare infection
5 Companies
4 Drugs
$
Success rate
D054312:Buruli ulcer
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaAzithromycin Azithromycin  2005-11-14   
Clarithromycin Clarithromycin  2005-05-31   
Taro PharmaceuticalAzithromycin Azithromycin  2019-12-11   
MylanAzithromycin Azithromycin  2007-05-30   
Clarithromycin Clarithromycin  2005-03-11   
Rising PharmaceuticalsAzithromycin Azithromycin  2007-05-30   
Amoxicillin, Lansoprazole, Clarithromycin Lansoprazole, Amoxicillin Clarithromycin  2016-10-07   
Lupin ResearchAzithromycin Azithromycin  2015-05-15   
Clarithromycin Clarithromycin  2015-09-15   
Ethambutol Ethambutol  2009-06-17   
SandozAzithromycin Azithromycin  2005-11-14   
Clarithromycin Clarithromycin  2005-08-25   
Amoxicillin, Lansoprazole, Clarithromycin Lansoprazole, Amoxicillin Clarithromycin  2014-03-04   
AbbVieClarithromycin Biaxin  1991-10-31   
PfizerAzithromycin, Trovafloxacin Trovan/zithromax Compliance  1998-12-18   
Azithromycin Zithromax  1991-11-01 $406 M Y2023 
TakedaAmoxicillin, Lansoprazole, Clarithromycin Prevpac  1997-12-02   
Aurobindo PharmaAzithromycin Azithromycin  2007-01-08   
Clarithromycin Clarithromycin  2012-07-25   
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
50%
1/2
Phase 2
36%
4/11
Phase 3
75%
6/8
Approved: 3Overall Success rate: 14%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Azithromycin,
Clarithromycin
Mylan
Azithromycin,
Clarithromycin
Sandoz
Azithromycin,
Clarithromycin
Pfizer
Azithromycin,
Lactams
Takeda
Amoxicillin,
Clarithromycin,
Lansoprazole
Sun Pharmaceutical Industries
Azithromycin
1
2
3
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use